Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Phase III Randomized Study of R-CHOP Versus DA-EPOCH-R and Molecular Analysis of Untreated Diffuse Large B-Cell Lymphoma: CALGB/Alliance 50303

Blood (2016) 128 (22): 469.

https://doi.org/10.1182/blood.V128.22.469.469

Published: 2016

Journal Articles

A Phase II Study of Dasatinib and Dexamethasone As Primary Therapy Followed By Hematopoietic Cell Transplantation for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: CALGB Study 10701 (Alliance)

Matthew J. Wieduwilt, MD PhD, Jun Yin, PhD, Meir Wetzler, MD, Geoffrey L. Uy, MD, Bayard L Powell, MD, Jonathan E. Kolitz, MD, Michaela Liedtke, MD, Wendy Stock, MD, Jan H. Beumer, PharmD, PhD, Ryan J. Mattison, MD, Alese Halvorson, Steven M. Devine, MD, Scott Smith, MD PhD, Richard M. Stone, MD, Richard A. Larson, MD

Blood (2016) 128 (22): 2782.

https://doi.org/10.1182/blood.V128.22.2782.2782

Published: 2016

Journal Articles

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis

Blood (2014) 124 (15): 2354–2361.

https://doi.org/10.1182/blood-2014-05-578963

Published: 2014

Includes: Supplemental data

Journal Articles

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era

Andrew M. Evens, Irene Helenowski, Erika Ramsdale, Chadi Nabhan, Reem Karmali, Britt Hanson, Benjamin Parsons, Scott Smith, Annette Larsen, June M. McKoy, Borko Jovanovic, Stephanie Gregory, Leo I. Gordon, Sonali M. Smith

Blood (2012) 119 (3): 692–695.

https://doi.org/10.1182/blood-2011-09-378414

Published: 2012

Includes: Supplemental data

Journal Articles

Marqibo ® (vincristine sulfate liposomes injection; VSLI) Optimizes the Dosing, Delivery, and Pharmacokinetic (PK) Profile of Vincristine Sulfate (VCR) In Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL)

Jeffrey A Silverman, PhD, Walter E. Aulitzky, MD, John Lister, MD, Lori Maness, M.D., Gary J Schiller, MD, Karen Seiter, MD, Scott Smith, MD, PhD, FACP, Wendy Stock, MD, Dina Ben Yehuda, Steven R. Deitcher, MD

Blood (2010) 116 (21): 2142.

https://doi.org/10.1182/blood.V116.21.2142.2142

Published: 2010

Journal Articles

Phase 2 Randomized Multicenter Study of Extended Dosing Schedules of Oral Ezatiostat HCl (Telintra), a Glutathione Analog Prodrug GSTP1-1 Inhibitor, In Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Azra Raza, MD, Naomi Galili, Ph.D., Scott Smith, MD, PhD, FACP, John E. Godwin, MD, MS, Ralph Boccia, MD, Han Myint, MD, Daruka Mahadevan, MD, PhD, Deborah Mulford, MD, Mark Rarick, MD, Mary Ann Allison, MD, Ostap Melnyk, MD, Lisa Meng, Marsha Jones, MD, Gail Brown, MD, Shelby A Young, RN, BSN, Mikkael A. Sekeres, MD, MS

Blood (2010) 116 (21): 2910.

https://doi.org/10.1182/blood.V116.21.2910.2910

Published: 2010

Journal Articles

Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.

Laura C Michaelis, MD, Danielle Shafer, DO, Kevin Barton, MD, Tulio Rodriguez, MD, Scott Smith, M.D., Ph.D, Patrick Stiff, MD, Sucha Nand, MD

Blood (2009) 114 (22): 1034.

https://doi.org/10.1182/blood.V114.22.1034.1034

Published: 2009

Journal Articles

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome

Azra Raza, Naomi Galili, Scott Smith, John Godwin, Jeffrey Lancet, Magda Melchert, Marsha Jones, James G. Keck, Lisa Meng, Gail L. Brown, Alan List

Blood (2009) 113 (26): 6533–6540.

https://doi.org/10.1182/blood-2009-01-176032

Published: 2009

Journal Articles

A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Aaron Gerds, MD, Mary Fox-Geiman, PharmD, Kevin Dawravoo, MD, Tulio Rodriguez, MD, Amir Toor, MD, Scott Smith, MD, PhD, Donna Fletcher-Gonzales, RPh, Chindo Hicks, PhD, Patrick Stiff, MD

Blood (2007) 110 (11): 479.

https://doi.org/10.1182/blood.V110.11.479.479

Published: 2007

Journal Articles

Amelioration of Late Complications Following Unrelated Donor Bone Marrow Transplantation When Anti-Thymocyte Globulin Is Used as a Part of Conditioning.

Matthew E. Adess, MD, Patrick Stiff, MD, Tulio Rodriguez, MD, John Norton, MS, Mala Parthasarthy, BS, Mary Fox-Geiman, PharmD, Scott Smith, MD, Amir Toor, MD

Blood (2006) 108 (11): 5319.

https://doi.org/10.1182/blood.V108.11.5319.5319

Published: 2006

Journal Articles

Azacitidine Plus Gemtuzumab Ozogamicin (GO): A Novel Combination in the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS) in the Elderly.

Sucha Nand, MD, John Godwin, MD, Scott Smith, MD, Kevin Barton, MD, Eliza Germano, BSN, Patrick Stiff, MD

Blood (2006) 108 (11): 1981.

https://doi.org/10.1182/blood.V108.11.1981.1981

Published: 2006

Journal Articles

Molecular Inhibition of mTOR with Temsirolimus (TORISEL™, CCI-779) Is a Promising Strategy in Relapsed NHL: The University of Chicago Phase II Consortium.

Sonali M. Smith, MD, Barbara Pro, MD, Scott Smith, MD, Patrick Stiff, MD, Eric Lester, MD, Sanjiv Modi, MD, Janet Dancey, MD, Everett E. Vokes, MD, Koen van Besien, MD

Blood (2006) 108 (11): 2483.

https://doi.org/10.1182/blood.V108.11.2483.2483

Published: 2006

NARROW

Phase III Randomized Study of R-CHOP Versus DA-EPOCH-R and Molecular Analysis of Untreated Diffuse Large B-Cell Lymphoma: CALGB/Alliance 50303

A Phase II Study of Dasatinib and Dexamethasone As Primary Therapy Followed By Hematopoietic Cell Transplantation for Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: CALGB Study 10701 (Alliance)

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era

Marqibo ® (vincristine sulfate liposomes injection; VSLI) Optimizes the Dosing, Delivery, and Pharmacokinetic (PK) Profile of Vincristine Sulfate (VCR) In Adults with Relapsed and Refractory Acute Lymphoblastic Leukemia (ALL)

Phase 2 Randomized Multicenter Study of Extended Dosing Schedules of Oral Ezatiostat HCl (Telintra), a Glutathione Analog Prodrug GSTP1-1 Inhibitor, In Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.

Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome

A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Amelioration of Late Complications Following Unrelated Donor Bone Marrow Transplantation When Anti-Thymocyte Globulin Is Used as a Part of Conditioning.

Azacitidine Plus Gemtuzumab Ozogamicin (GO): A Novel Combination in the Treatment of Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS) in the Elderly.

Molecular Inhibition of mTOR with Temsirolimus (TORISEL™, CCI-779) Is a Promising Strategy in Relapsed NHL: The University of Chicago Phase II Consortium.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only